Margo Beller

Margo D. Beller's career has spanned from print magazines to daily newspapers to electronic newswires to business websites. She began as a reporter and columnist covering the insurance and banking industries during the heady days of federal deregulation. After a short stint in management, she moved into copy editing and has since enjoyed a long association with Dow Jones Newswires and, more recently, with CNBC.com and TheStreet.com.

At TheStreet.com she copy edits articles filed by contributing writers, columns and, in the evenings, the daily Mad Money recap written by Scott Rutt plus two subsidiary features based on that which run the next morning. She manages copy and edits and publishes the nightly tech roundup and any copy not handled by her afternoon colleagues. She is a go-to person for information on style.

Based in Morris County, New Jersey, her other interests are varied. She is a nature and editorial writer for several blogs, including her own.

Recent Articles By The Author

Jim Cramer's Top Takeaways: Marathon Petroleum, Salesforce, Facebook, Cimarex Energy

Jim Cramer's Top Takeaways: Marathon Petroleum, Salesforce, Facebook, Cimarex Energy

Cramer says Salesforce and Facebook are worth buying and he's optimistic about Cimarex Energy.

Jim Cramer's Top Takeaways: American Water Works, Aqua America, SiteOne, Dominion Resources

Jim Cramer's Top Takeaways: American Water Works, Aqua America, SiteOne, Dominion Resources

Cramer says American Water Works and Aqua America are in a 'stealth' bull market and you should buy Dominion Resources on any pullback.

Jim Cramer's Top Takeaways: Splunk, Chipotle Mexican Grill, Henry Schein

Jim Cramer's Top Takeaways: Splunk, Chipotle Mexican Grill, Henry Schein

Cramer says Splunk is in the early innings of growth, Chipotle may be jinxed and Henry Schein is a buy.

Jim Cramer's Top Takeaways: AT&T, Nexstar Broadcasting, Valeant, Ollie's

Jim Cramer's Top Takeaways: AT&T, Nexstar Broadcasting, Valeant, Ollie's

Investors will be able to buy quality companies including AT&T and Bristol-Myers at bargain rates next week, Cramer says. But avoid Valeant at all cost.

Jim Cramer's Top Takeaways: Masco, J.M. Smucker, Juno Therapeutics, Johnson & Johnson

Jim Cramer's Top Takeaways: Masco, J.M. Smucker, Juno Therapeutics, Johnson & Johnson

Masco could be setting up for a bounce, Cramer says, and Smucker is just the kind of company you should buy on a pullback.